Overview

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

To evaluate the safety, bio-distribution, and radiation dosimetry; and to optimize the Imaging Protocol of GEH120714 (18F) Injection. Study recruits healthy volunteers and participants with relapsing and remitting multiple sclerosis.

Phase:

Phase 1

Details

Lead Sponsor:

GE Healthcare

Collaborator:

Centre for Probe Development and Commercialization